249420 — Il Dong Pharmaceutical Share News
0.000.00%
Last trade - 00:00- KR₩404bn
- KR₩484bn
- KR₩567bn
To Divest 15.85 Billion Won Worth Of Shares In D&D Pharmatech
Brief: Il Dong Pharmaceutical Q3 Operating Profit 6.8 Billion Won, Up 87.6% From Year Earlier
Brief: Il Dong Pharmaceutical Q2 Operating Profit 596 Million Won, Down 41.4% From Year Earlier
Brief: Il Dong Pharmaceutical Q1 Operating Profit 4.2 Billion Won, Up 4275% From Year Earlier
Brief: Il Dong Pharmaceutical Q4 Operating Profit 10.7 Billion Won, Swings To Profit From Year Earlier
Brief: Il Dong Pharmaceutical Q2 Consolidated Operating Profit 5 Billion Won, Swings To Profit From Year Earlier
Brief: Il Dong Pharmaceutical Q1 Consolidated Operating Profit 96 Million Won, Swings To Profit From Year Earlier
Brief: Il Dong Pharmaceutical Q4 Consolidated Operating Loss 3 Billion Won, Up 87% From Year Earlier
Brief: Il Dong Pharmaceutical Q4 Operating Profit 7.6 Billion Won, Swings To Profit From Year Earlier
Brief: Il Dong Pharmaceutical Q3 Operating Loss 16 Billion Won, Up 13.6% From Year Earlier
Brief: Il Dong Pharmaceutical Q2 Operating Loss 18 Billion Won, Up 18% From Year Earlier
Brief: Il Dong Pharmaceutical Q3 Operating Loss 18.6 Billion Won, Down 34% From Year Earlier
Brief: Il Dong Pharmaceutical Says S.Korea Ministry Of Food And Drug Safety Accepts Second Phase Clinical Trials For Covid-19 Oral Treatment
Brief: IL Dong Pharmaceutical to pay annual cash dividend as 400 won/share
Brief: Il Dong Pharmaceutical says annual dividend for 2016
Brief: IL Dong Pharmaceutical receives patent